TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen

Amgen to Join LAB150 to Build Canada’s Next Generation of Life Science Companies TORONTO, Canada & HAMBURG, Germany–(BUSINESS WIRE)–#LifeSciences–Toronto Innovation Acceleration Partners (“TIAP”) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. … [Read more…]

Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the full market release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems (2.00 Max Crown). Built on the proven Diamondback 360® Orbital Atherectomy … [Read more…]

Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-323, its Novel, Oral L-Protein Inhibitor in Development for the Treatment Respiratory Syncytial Virus

WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it has dosed the first subject in its Phase 1 clinical trial of EDP-323, a novel, oral L-protein inhibitor in development for the treatment of respiratory syncytial virus (RSV). “This … [Read more…]

PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced it will release its full third quarter 2022 financial results on November 8, 2022. Management will host a webcast the same day at 8:00 a.m. ET to discuss these results. To access the call, a live audio … [Read more…]

An Open Letter to Mednow Investors

Mednow Co-Founder and CEO Ali Reyhany shares key financial results and indicators, recaps accomplishments and adds context on the macroeconomic climate and its impact TORONTO–(BUSINESS WIRE)–$MNOW #healthcare–Mednow Inc (TSXV: MNOW) (OTCQX:MDNWF) — Mednow Co-Founder and CEO Ali Reyhany shared an open letter with investors detailing key achievements and milestones over the past 18 months as … [Read more…]

Biodesix Awarded U.S. Federal Supply Schedule Contract for Its Comprehensive Lung Cancer Diagnostic Testing Solutions

Expands Coverage to Veterans Health Administration and Military Health System Medical Centers for Its Entire Lung Diagnostic Portfolio BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the award of a U.S. Federal Supply Schedule contract which includes the Veterans Health Administration providing … [Read more…]

Vivani Medical to Present at the ThinkEquity Investor Conference

EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced today that it will present at the upcoming ThinkEquity investor conference at 11:00 am EDT at the Mandarin Oriental in New York on October 26, 2022. Dr. Adam Mendelsohn, CEO, will present … [Read more…]

Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14

WIXOM, Mich.–(BUSINESS WIRE)–$RMTI #blooddisorders–Rockwell Medical, Inc. (Nasdaq:RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that it will release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. The Company will issue a … [Read more…]

Babylon Announces Private Placement Financing

AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE: BBLN) (“Babylon” or the “Company”) today announced that it has agreed to sell an aggregate of 145,885,760 (prior to rounding of fractional shares) of its Class A ordinary shares to certain institutional and other accredited investors (the “Initial Subscribers”) in a private investment in public equity (the “PIPE”) at … [Read more…]

Advanced Pharmacovigilance Auditing and Inspections Course (January 12-13, 2023) – ResearchAndMarkets.com

DUBLINDUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance Auditing and Inspections Course” training has been added to ResearchAndMarkets.com’s offering. Pharmacovigilance Auditing and Inspections Virtual Live Training Course This seminar will also have a focus on the risk base approaches in response to COVID – 19 including recent legislation governing the conduct of these activities. PV Audit Strategy Planning course … [Read more…]